Epilepsy is defined as the repetition of seizures, with varied symptomatology, whose spontaneous and unpredictable nature accounts for the chronic disability in patients. About one-third of patients are resistant to antiepileptic drugs, i.e. uncontrolled epileptic seizures despite at least two adequate molecules. The study of the mechanisms underlying the transition between an interictal state (literally “between two seizures”) and the seizure – also known as ictogenesis – has long suggested the existence of preictal modifications. The preictal state, which refers to the period preceding the seizure, is the cornerstone of seizure prediction methods. Identifying sensitive and specific preictal biomarkers would be an opportunity for therapeut...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Epilepsy is defined as the repetition of seizures, with varied symptomatology, whose spontaneous and...
L’épilepsie se définit comme la répétition de crises, de symptomatologie variée, mais dont le caract...
Many patients with drug-resistant epilepsy are in need of alternative therapeutic approaches. Seizur...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
The effects of electrical stimulation on the dynamics of epileptic neural systems are still unknown....
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Epilepsy is defined as the repetition of seizures, with varied symptomatology, whose spontaneous and...
L’épilepsie se définit comme la répétition de crises, de symptomatologie variée, mais dont le caract...
Many patients with drug-resistant epilepsy are in need of alternative therapeutic approaches. Seizur...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
Epilepsy is a chronic pathology defined by the repetition of clinical paroxysmal manifestations call...
The effects of electrical stimulation on the dynamics of epileptic neural systems are still unknown....
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Despite the diversity of anti-epileptic drugs available to reduce neuronal excitability, nearly one-...
Symptomatic pharmacological treatments currently marketed for Alzheimer’s disease (AD) have a modest...